Bayer Cropscience India Limited Revenue Breakdown – NSE:BAYERCROP
NiveshIQ
NSE: BAYERCROP · Chemicals
Bayer Cropscience Ltd.
₹4,248.30▲ ₹28.90 (+0.68%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on BAYERCROP. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Bayer Cropscience Ltd.
Bayer CropScience Limited is a leading player in the Indian agrochemicals market, with a diversified portfolio of insecticides, fungicides, herbicides, and hybrid corn seeds. The company's key revenue drivers include its insecticides and fungicides segment, which accounted for a significant share of its total revenue. Recent developments include the launch of Velum Prime, a fungicide for high-value vegetables, and the company's increasing focus on digital farming products and tools. Bayer CropScience Limited competes with other major players in the Indian agrochemicals market, including UPL and Rallis India. The company's growth outlook is driven by increasing demand for agrochemicals in India, as well as its expanding presence in the digital farming space. With a strong product portfolio
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹4,892 Cr -1.10% | ₹5,314 Cr +8.60% | ₹5,675 Cr +6.80% |
| EBITDA Margin | 21.16% | 15.23% | 17.07% |
| Net Profit | ₹740.50 Cr -2.30% | ₹568.00 Cr -23.30% | ₹689.20 Cr +21.30% |
| EPS | ₹164.77 | ₹126.38 | ₹153.35 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Bayer stock trades steady as Crop Science outlook and litigation provisions shape valuation
Bayer stock trades steady as patent loss and pipeline focus shape investor debate
🔒
+ 3 more stories about Bayer Cropscience Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹1, 101 Cr, PAT ₹162 Cr, EPS ₹36.07, EBITDA margin 22.7%. Growth context: revenue YoY +23.9%, PAT YoY +13.1%, revenue QoQ -0.5%, PAT QoQ +69.4%. Street verdict: inline, revenue surprise -0.6%, PAT surprise +2.4%.
Recent corporate activity highlights R&D investments and technology initiatives as the primary near-term growth lever, w...
FY26 (last completed FY): revenue ₹5, 675 Cr, PAT ₹689 Cr, EBITDA margin 17.1%, EPS ₹153.35. Year-on-year: revenue YoY +...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for BAYERCROP
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track BAYERCROP alongside your other holdings
Unlock full BAYERCROP research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Bayer Cropscience Ltd.?
NiveshIQ detects active intelligence signals for Bayer Cropscience Ltd. (BAYERCROP) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Bayer Cropscience Ltd.?
Bayer Cropscience Ltd. operates in the Chemicals sector with a market capitalisation of ₹2,067,381.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.